跳至主要内容
临床试验/JPRN-UMIN000001184
JPRN-UMIN000001184已完成1 期

Clinical study of alpha-GalactosylCeramide-pulsed dendritic cells in patients with operable primary lung cancer. - Clinical study of alpha-GalactosylCeramide-pulsed dendritic cells in patients with operable primary lung cancer.

Department of Thoracic Surgery, Graduate School of Medicine, Chiba University0 个研究点目标入组 20 人开始时间: 2008年6月12日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients who have been treated with surgery or chemotherapy or radiotherapy received for at least 4 weeks before enrollment. 2. Histology is large cell neuroendocrine carcinoma. 3. The exclusion criteria were a positive response to HIV, hepatitis C virus, or human T-cell lymphotrophic virus antibodies; positive for hepatitis B antigen; the presence of active inflammatory disease or active autoimmune disease; a history of hepatitis; pregnancy or lactation; concurrent corticosteroid therapy; and evidence for another active malignant neoplasm. The histologic type, tumor-node-metastasis classification, and the antitumor effect of treatment were classified according to the general rules for clinical and pathologic recording of lung cancer as described by the Japan Lung Cancer Society.

研究者

发起方
Department of Thoracic Surgery, Graduate School of Medicine, Chiba University

相似试验